Clinical Trial Update: Two Cycles of PAD Combination by AHCT in MM [Phase 2]

View source ↗

Summary

A phase 2 trial assessing two cycles of the PAD regimen given with autologous hematopoietic cell transplantation in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (Velcade) (Bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Doxorubicin (Adriamycin) (doxorubicin)

Snippet

Sponsor: Cooperative Study Group A for Hematology | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED